DK1407267T3 - Gelsammensætninger - Google Patents

Gelsammensætninger

Info

Publication number
DK1407267T3
DK1407267T3 DK02745605.2T DK02745605T DK1407267T3 DK 1407267 T3 DK1407267 T3 DK 1407267T3 DK 02745605 T DK02745605 T DK 02745605T DK 1407267 T3 DK1407267 T3 DK 1407267T3
Authority
DK
Denmark
Prior art keywords
gel
analyte
moieties
sol
entities
Prior art date
Application number
DK02745605.2T
Other languages
Danish (da)
English (en)
Inventor
Margaret Joan Taylor
Original Assignee
Univ Montfort
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montfort filed Critical Univ Montfort
Application granted granted Critical
Publication of DK1407267T3 publication Critical patent/DK1407267T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Colloid Chemistry (AREA)
DK02745605.2T 2001-07-10 2002-07-10 Gelsammensætninger DK1407267T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0116860.8A GB0116860D0 (en) 2001-07-10 2001-07-10 Gel compositions
PCT/GB2002/003183 WO2003006993A2 (en) 2001-07-10 2002-07-10 Gel compositions

Publications (1)

Publication Number Publication Date
DK1407267T3 true DK1407267T3 (da) 2011-09-19

Family

ID=9918254

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02745605.2T DK1407267T3 (da) 2001-07-10 2002-07-10 Gelsammensætninger

Country Status (9)

Country Link
US (1) US8247391B2 (enExample)
EP (1) EP1407267B1 (enExample)
JP (2) JP2004534103A (enExample)
AT (1) ATE513214T1 (enExample)
DK (1) DK1407267T3 (enExample)
ES (1) ES2368036T3 (enExample)
GB (1) GB0116860D0 (enExample)
PT (1) PT1407267E (enExample)
WO (1) WO2003006993A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0116860D0 (en) 2001-07-10 2001-09-05 Univ Montfort Gel compositions
DE10254636A1 (de) * 2002-11-22 2004-06-09 Capsulution Nanoscience Ag Verfahren zum Modifizieren von Mikropartikeln sowie Vorrichtung zum Modifizieren von Mikropartikeln
CA3066594A1 (en) * 2004-10-08 2006-04-20 Georgia Tech Research Corporation Microencapsulation of cells in hydrogels using electrostatic potentials
CN102325814B (zh) * 2009-01-14 2014-03-12 康奈尔大学 用于生物医学用途的生物可降解型水凝胶的制备
CN101745114B (zh) * 2009-12-25 2013-01-23 浙江工业大学 一种对葡萄糖敏感可自控释胰岛素的生物材料的制备方法
US20140350370A1 (en) * 2013-04-08 2014-11-27 The Texas A&M University System Glucose sensing assay
GB201310185D0 (en) 2013-06-07 2013-07-24 Univ Montfort Container
GB201314640D0 (en) * 2013-08-15 2013-10-02 Univ Montfort Matrix gel
CN113350489A (zh) 2015-04-21 2021-09-07 北卡罗来纳州立大学 使用缺氧敏感性纳米复合材料的葡萄糖响应性胰岛素递送系统
CN108366960B (zh) * 2015-10-23 2022-04-19 国立大学法人东京医科齿科大学 药物递送装置
WO2018085809A1 (en) 2016-11-07 2018-05-11 North Carolina State University Patch loaded with dual-sensitive vesicles for enhanced glucose-responsive insulin delivery
NO343313B1 (en) * 2017-03-15 2019-01-28 Lifecare As Fluid composition, method for preparing the composition and use
BR112021011103A8 (pt) * 2018-12-18 2022-08-09 Currahee Holding Company Inc Emplastro personalizado para aplicação tópica
US20220370493A1 (en) * 2019-06-04 2022-11-24 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
AU2020286987B2 (en) * 2019-06-04 2025-09-11 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
TWI899548B (zh) * 2023-03-13 2025-10-01 羅怡情 染髮用凝膠的用途及製法
CN121243060B (zh) * 2025-11-07 2026-08-11 江苏知原药业股份有限公司 一种高稳定性的阿达帕林凝胶的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705503A (en) * 1986-02-03 1987-11-10 Regents Of The University Of Minnesota Metabolite sensor including a chemical concentration sensitive flow controller for a drug delivery system
GB9200638D0 (en) 1992-01-10 1992-03-11 Leicester Polytechnic Drug system
DE4203466A1 (de) 1992-02-04 1993-08-05 Rudolf Prof Dr Ehwald Affinitaets-sensor
GB9313484D0 (en) * 1993-06-30 1993-08-11 Univ Montfort Drug system ii
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
JP3536186B2 (ja) * 1995-02-27 2004-06-07 独立行政法人 科学技術振興機構 生体内分解性高分子ヒドロゲル
US5889028A (en) * 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
WO1998022097A2 (en) * 1996-11-20 1998-05-28 Bio Advances, Llc Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
GB9805896D0 (en) 1998-03-20 1998-05-13 Eglise David Remote analysis system
CA2337667C (en) 1998-08-10 2008-04-29 Amgen Inc. Dextran-leptin conjugates, pharmaceutical compositions and related methods
AU6931500A (en) 1999-08-27 2001-03-26 M-Biotech, Inc. Glucose biosensor
GB0116860D0 (en) 2001-07-10 2001-09-05 Univ Montfort Gel compositions

Also Published As

Publication number Publication date
GB0116860D0 (en) 2001-09-05
ATE513214T1 (de) 2011-07-15
PT1407267E (pt) 2011-09-19
EP1407267A2 (en) 2004-04-14
WO2003006993A2 (en) 2003-01-23
JP2004534103A (ja) 2004-11-11
US8247391B2 (en) 2012-08-21
US20040265386A1 (en) 2004-12-30
WO2003006993A3 (en) 2003-09-25
JP5405511B2 (ja) 2014-02-05
EP1407267B1 (en) 2011-06-15
JP2011144197A (ja) 2011-07-28
ES2368036T3 (es) 2011-11-11

Similar Documents

Publication Publication Date Title
ATE513214T1 (de) Gelzusammensetzungen
ATE278191T1 (de) Messung und verwendung von molekularen wechselwirkungen
MA27035A1 (fr) Ligands de recepteurs de 5-ht et leurs utilisations
DE50105338D1 (de) Neuartige polymerbindersysteme mit ionischen flüssigkeiten
BR0200472B1 (pt) composiÇço de fluido de hidrocarboneto lÍquido em forma de gel, e, agente de formaÇço de gel de lÍquido de hidrocarboneto.
DE69830257D1 (de) Verwendung von Interleukin-15
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
ATE412432T1 (de) Internalisierende erbb2 antikörper
EP1572881A4 (en) POLYPEPTIDE TACIS AND BR3 AND USES THEREOF
CY1119291T1 (el) Πολυσθενη αντισωματα και χρησεις για αυτα
MXPA03008957A (es) Modulacion de interacciones de pd-1 con sus ligandos.
FI964732A0 (fi) Kahden SIM-kortin käyttäminen samalla MSISDN-numerolla
DE50306232D1 (de) Ampholytisches copolymer und dessen verwendung
AU1628100A (en) Bidirectional lateral flow test strip and method
EP0894807A4 (en) GPIb lipid complex and its applications
DE69835882D1 (de) Detektion der datenrate für cdma übertragungssysteme mit variabler datenrate
DK1228147T3 (da) Farvemærkede imidazoquinolinforbindelser
DE60115217D1 (de) Alprazolam inklusion-komplexe und ihre pharmazeutischen zusammensetzungen
DE60010761D1 (de) Initiator/amidine komplexe, solche komplexe enthaltende systeme, und damit hergestellte polymerisierte zusammensetzungen
DE60231742D1 (de) Formulierung enthaltend eine anionische verbindung, ein polyionisches polymer und ein copolymer
EP0875567A3 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
TR200002987T2 (tr) Optik özelliklere sahip olan poli (Alkilen Arilatlar).
WO2002079980A3 (en) Software customisation
TR200102877T2 (tr) İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar.
ID26611A (id) Turunan-turunan pirol tersubstitusi heteroaril, pembuatannya dan kegunaan-kegunaan terapetiknya